Ketoprofen has analgesic and antipyretic properties and belongs to the non-steroidal anti-inflammatory drug (NSAID) family. It also has pharmacologic actions quite similar to the other archetypical NSAIDs, which hinder prostaglandin synthesis. This drug is used for treating fever, pain, inflammation, dysmenorrheal, rheumatoid arthritis, osteoarthritis, and also to decrease the moderate pain’s intensity. Ketoprofen impacts on cyclooxygenase enzyme, to lessen the prostaglandin chemicals’ levels. Besides, this drug is also prescribed in cases of treating ankylosing spondylitis, acute and chronic rheumatoid arthritis, gout, sprain, lower back pain, pain related to musculotendinous trauma, primary dysmenorrheal, postoperative and postpartum pain. The drug functions by lessening the hormones that cause inflammation and pain inside the human body. Nevertheless, ketoprofen is known to produce several side effects like headaches, loss of appetite, stomach pain, nausea, vomiting, liver trob;es, indigestion, etc. In rare cases, this drug also causes stroke, heart attack, and fatal blood vessels, especially in case of long terms usage. Hence, a patient is strictly adviced not to consume this medicine prior to a bypass surgery. A few medicines such as pentoxifylline, ciclosporin, ACE inhibitors, methotrexate, warfarin, and aspirin counteract with ketoprofen resulting in several complications like lowering the blood pressure or lithium toxicity.
Get Sample Report @ http://www.qyresearchgroups.com/request-sample/311544
The global ketoprofen market is expected to garner lucrative growth in terms of revenue share in the future and will register as a substantial CAGR during the forecast period. Factors such as increasing geriatric population, high prevalence of obesity, rise in adapting to the sedentary lifestyle, wide occurrence of bone and joint disorders, are accountable for the positive growth of this industry’s market. Furthermore, escalating healthcare awareness and more and more number of surgeries across the globe are also fuelling this market on a global level. Region-wise, Europe is said to predominate the global ketoprofen market owing to the increasing aged population and elevating junk food habits and also sedentary lifestyle. Also, Asia is predicted to witness higher growth rates in the coming five years in this market. Moreover, a few prominent driving forces for ketoprofen market in developing countries are rising healthcare expenditure, increase in government funding, and broad pool of patients. Nonetheless, rigorous regulations for government approvals of the drug and side-effects might hinder the market growth. Also, innovation of novel therapeutic analgesics and more number of herbal products can be a challenge for the global market of ketoprofen.
Browse Complete Report @ http://www.qyresearchgroups.com/report/global-ketoprofen-market-research-report-2017
The major market manufacturers of the global ketoprofen market are SANOFI-Aventis, Boehringer-Ingelheim, BEC, Zhejiang Jiuzhou, Schein Pharmaceutical and Hubei Xunda. Regional market of this industry has been segmented into North America, Europe, China, Japan, Southeast Asia, and India. Lastly, the end-user applications of this market industry on a global level are ketoprofen tablets, ketoprofen capsules, ketoprofen gel, and others.
QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world’s most complete and current database of expert insights on global industries, companies, products, and trends.
Room B1510, ShijiKemao Building, No.66, Zhongguancun East Road,
Haidian District, Beijing, 100190, China